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Objectives—To examine intelligence, language, and academic achievement through 18 years of 
age among children with congenital CMV infection identified through hospital-based newborn 
screening who were asymptomatic at birth compared to uninfected infants.
Methods—We used growth curve modeling to analyze trends in intelligence quotient (full-scale, 
verbal and non-verbal intelligence), receptive and expressive vocabulary, and academic 
achievement in math and reading. Separate models were fit for each outcome, modeling the 
change in overall scores with increasing age for case-patients with normal hearing (n=78) or with 
sensorineural hearing loss (SNHL) diagnosed by 2 years of age (n=11) and controls (n=40).
Results—Case-patients with SNHL had full-scale intelligence and receptive vocabulary scores 
that were 7.0 and 13.1 points lower, respectively, compared to controls, but no significant 
differences were noted in these scores among case-patients with normal hearing and controls. No 
significant differences were noted in scores for verbal and non-verbal intelligence, expressive 
vocabulary, and academic achievement in math and reading among case-patients with normal 
hearing or with SNHL and controls.
Conclusions—Infants with asymptomatic congenital CMV infection identified through newborn 
screening with normal hearing by age 2 years do not appear to have differences in intelligence 
quotient, vocabulary or academic achievement scores during childhood or adolescence compared 
with uninfected children.
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INTRODUCTION
Approximately 20,000 (0.5%) children are born with congenital cytomegalovirus (CMV) 
infection annually in the United States1, 2, of which 85–90% appear asymptomatic at 
birth.3, 4 The extent to which asymptomatic congenital CMV infection is associated with 
increased risk of intellectual impairment or low academic achievement throughout childhood 
is not well established. Several studies have found no differences in intelligence or various 
cognitive domains among children with asymptomatic congenital CMV infection identified 
by newborn screening compared to uninfected children.5–16 The largest study included 159 
children with asymptomatic congenital CMV infection and 130 uninfected children between 
ages 1–13 years, although <20% of all children received assessments at age ≥7 years.5 Most 
other studies followed a small number of children with asymptomatic congenital CMV 
infection (median: 32, range: 15–60)6–11, 16 through ≤5 years of age.7, 9, 10, 12, 13, 16 In this 
study, we examined intelligence, language, and academic achievement among children with 
asymptomatic congenital CMV infection identified through hospital-based newborn 
screening and uninfected children followed through age 18 years.
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METHODS
Study population
During 1982–1992, newborns delivered at Women’s Hospital of Texas (Houston TX) were 
screened for congenital CMV infection via urine culture within the first 3 days of life.17–19 
Of 32,543 screened newborns, 135 (0.4%) were CMV-positive. Ninety-two (68%) infected 
newborns with no CMV-related signs at birth (i.e. purpura/petechiae, jaundice, 
hepatosplenomegaly, microcephaly, elevated liver enzymes, bilirubinemia, hemolytic anemia 
or thrombocytopenia) were enrolled in a longitudinal study as asymptomatic case-patients, 
along with 42 unmatched controls identified among 298 CMV-negative infants born within 6 
days of a CMV-positive infant’s birth.19 All children received audiological assessments from 
birth to age 18 years. SNHL outcomes have been previously described for this cohort19, as 
well as intelligence quotient at age ≥6 years for a subgroup of 58 case-patients and 12 
children with symptomatic congenital CMV disease.20 For this analysis, we categorized 
children based on their hearing status by age 2 years. Children diagnosed with SNHL (i.e. 
≥25 dB hearing level at any frequency) after age 2 years were categorized as having normal 
hearing; none of the controls were diagnosed with SNHL by age 2 years. Thus, our analysis 
included case-patients with normal hearing, case-patients with SNHL, and controls.
Neurodevelopmental assessments
Neurodevelopmental pediatricians and/or psychologists assessed study children using norm-
referenced instruments appropriate for age and verbal ability, ensuring proper 
accomodations for those with SNHL or whose first language was not English were provided 
during testing, e.g. children used their hearing aids and/or were accompanied by a sign or 
foreign language interpreter. Assessments were conducted at least once during the infancy, 
pre-school, elementary, middle, and high school years, including measures of intelligence, 
language skills, and academic achievement.
We analyzed longitudinal trends in intelligence quotient (full-scale, verbal and non-verbal 
intelligence) combining scores from the Wechsler Intelligence Scale for Children (WISC) 
3rd edition21 and the Wechsler Abbreviated Scale of Intelligence (WASI)22 at ages 6–18 
years; the WISC was subsequently replaced by the WASI in later years of the study. We also 
analyzed trends by combining full-scale intelligence scores from the WISC and WASI21, 22 
with the mental scale score from the Bayley Scales of Infant Development23 at ages 0–1 year 
and the general cognitive index score from the McCarthy Scales of Children’s Abilities24 at 
ages 2–5 years. Because trends for the full-scale intelligence with and without tests at 
younger ages were similar, we report results of the analysis including scores from all tests.
For language skills, we assessed receptive vocabulary, the ability to understand words, using 
the Peabody Picture Vocabulary Test – Revised25, and expressive vocabulary, the ability to 
communicate using words, using the Expressive One Word Picture Test – Revised.26 For 
academic achievement, we assessed the broad math and broad reading scores of the 
Woodcock-Johnson Tests of Achievement – Revised.27 Scores on all tests have a mean of 
100 with a standard deviation of 15 or 16. We categorized children with any of the 
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intelligence scores <85 as at risk for intellectual impairment28, and those with academic 
achievement scores in math or reading <85 as having low academic achievement.
Statistical Analysis
We compared maternal sociodemographic characteristics collected at birth, including age, 
race/ethnicity, marital status, education, health insurance, and socioeconomic status between 
case-patients with normal hearing, with SNHL and controls using Fisher’s exact test. 
Socioeconomic status was derived by combining census data on socioeconomic 
characteristics by zip code of residence at birth and health insurance information.29 We used 
growth curve modeling30 to analyze trends in full-scale, verbal and non-verbal intelligence, 
receptive and expressive vocabulary, and academic achievement in math and reading with 
increasing age. For each neurodevelopmental measure, we initially fit a model including the 
child’s age, group (i.e., case-patient with normal hearing, case-patient with SNHL, or 
control), and mother’s education (some college or less vs. graduated college or more) 
because of its potential impact on children’s outcomes. The initial models included a small 
number of variables, thus, we did not adjust for multiple comparisons. We modeled the 
change in overall scores with age linearly, unless there was curvature in the scores with age, 
in which case, we added a quadratic term for age. We included random effects for intercepts 
and slopes. We used the likelihood ratio test and backward elimination to remove the least 
significant variable one-by-one until all variables in the model remained significant at 
P<0.05. We report the effect estimate and standard error (SE) for each variable that was 
significant in the final models. We calculated the mean test scores for each group of children 
adjusting for maternal education, if it was significant in the final model. We report mean 
scores and likelihood 95% confidence intervals (CI) at ages 5 and 18 years for scores that 
increased linearly with age, and at ages 5, 12, and 18 years for scores that showed a 
curvature with age. We performed data analysis using SAS (version 9.3, SAS Institute, Cary, 
North Carolina) and R software (version 3.2.1, R Foundation for Statistical Computing, 
Vienna, Austria), and fitted growth curve models using the R package “lme4.”31
RESULTS
Eighty-nine (97%) of 92 case-patients and 40 (95%) of 42 controls enrolled in the 
longitudinal study had neurodevelopmental assessments and were included in this analysis. 
Overall, 20 case-patients and 3 controls were diagnosed with SNHL, at median ages of 16 
months (range: 1 month–18 years) and 11 years (range: 9–15), respectively. Eleven case-
patients were diagnosed with SNHL by age 2 years, among whom 9 had moderate to 
profound SNHL (>40 dB) at age 2 years; 2 progressed to those levels later. All 9 case-
patients and 3 controls diagnosed with SNHL after age 2 years had SNHL ≤40 dB in the 
poorer-hearing ear, except one case-patient diagnosed with mild unilateral SNHL at age 5 
years, which progressed to severe by age 8 years. Thus, our analyses consisted of 
comparisons among 78 case-patients with normal hearing, 11 case-patients with SNHL by 
age 2 years, and 40 controls.
A majority of the children were born to non-Hispanic white mothers, aged 20–40 years, 
married, who had at least some college education and medium/high socioeconomic status, 
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with no statistically significant differences among the 3 groups, except for health insurance 
status (Table 1). Median age at last assessment among all 3 groups was 13 years for 
expressive vocabulary and 17 years for all other measures (Table 2). Median number of 
measures of full-scale intelligence (including tests at younger ages) was greater among case-
patients with normal hearing or with SNHL compared with controls.
Intelligence
Among 75 case-patients with normal hearing, 11 case-patients with SNHL, and 39 controls, 
scores <85 were recorded as follows: 6 (8%), 3 (27%), and 5 (13%), respectively, on the 
Bayley scales; 6 (8%), 2 (18%), 3 (8%) on the McCarthy scales; and 4 (5%), 1 (9%), and 3 
(8%) on the WISC and/or WASI. Among children with scores <85 in the Bayley scales, 4 
case-patients with normal hearing and 1 case-patient with SNHL were lost to follow-up; 
only 1 case-patient with normal hearing and one control had scores <85 in more than one 
assessment.
Full-scale intelligence scores increased linearly with increasing age (0.2 points per year, 
SE=0.1; P<0.05), but the rate of change did not differ among the 3 groups. Mean (95% CI) 
full-scale intelligence scores adjusted for mother’s education at age 5 and 18 years were, 
respectively, 108 (105–110) and 111 (108–114) for case-patients with normal hearing, 101 
(95–106) and 104 (98–110) for case-patients with SNHL, and 108 (104–111) and 111 (107–
114) for controls. Full-scale intelligence scores for case-patients with normal hearing did not 
differ from controls at either time point (P=0.96). Case-patients with SNHL had scores that 
were 7.0 (SE=0.3) points lower compared to controls (P<0.05). Children of mothers who 
graduated college had full-scale intelligence scores that were 3.5 (SE=1.7) points higher 
compared to children of mothers with some college or less education (P<0.05).
Verbal and non-verbal intelligence scores did not change significantly with increasing age. 
Mean (95% CI) verbal and non-verbal intelligence scores adjusted for mother’s education 
were 107 (105–109) and 109 (107–111), respectively, with no significant differences among 
the 3 groups. Children of mothers who graduated college had verbal and non-verbal scores 
that were 4.4 (SE=2.1) and 4.0 (SE=1.9) points higher, respectively, compared to children of 
mothers with some college or less education (P<0.05 for both).
Language
Receptive vocabulary scores increased until 12.5 years and declined slightly thereafter 
[effect estimates (SD): 3.0 (0.5) for linear term and 0.1 (0.02) for quadratic term; P<0.001 
for both]. Mean (95% CI) receptive vocabulary scores at ages 5, 12, and 18 years were 100 
(97–103), 107 (104–110), and 104 (100–107) for case-patients with normal hearing, 
respectively; 89 (82–97), 96 (89–104), and 93 (85–101) for case-patients with SNHL; and 
102 (98–107), 109 (105–114), and 106 (101–111) for controls. Case-patients with SNHL 
had receptive vocabulary scores that were 13.1 (SE=4.2) points lower compared to controls 
(P<0.05); the difference in scores between case-patients with normal hearing and controls 
was not statistically significant (2.4; SE=2.6; P=0.36).
Expressive vocabulary scores decreased linearly with increasing age for all 3 groups (1.8 
points per year; SE=0.3; P<0.05). Mean (95% CI) expressive vocabulary scores at ages 5 
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and 18 years were 120 (115–125) and 96 (91–101), with no significant differences among 
the 3 groups. Maternal education was not significantly associated with either receptive or 
expressive language scores for any of the groups. The pattern of change in either receptive or 
expressive vocabulary scores did not differ among the 3 groups.
Academic achievement
Among 70 case-patients with normal hearing, 8 (11%) had low academic achievement 
(scores <85; 6 in math only, 1 in reading, 1 in both). None of the 11 case-patients with 
SNHL had low academic achievement in math or reading. One (3%) of 39 controls had low 
academic achievement in math.
Academic achievement scores in math decreased linearly with increasing age for all 3 
groups (0.6 points per year; SE=0.2; P<0.05). Mean (95% CI) math scores adjusted for 
mother’s education were 117 (113–121) at age 5 years and 109 (106–112) at age 18 years, 
with no significant differences among the 3 groups. Children of mothers who graduated 
college had scores that were 7.4 (SE=2.6) points higher compared to children of mothers 
with some college or less education (P<0.05).
Academic achievement scores in reading did not change with increasing age. The mean 
(95% CI) reading score adjusted for mother’s education was 112 (109–114), with no 
significant differences among the 3 groups. Children of mothers who graduated college had 
scores that were 6.5 (SE=2.5) points higher compared to children of mothers with some 
college or less education (P<0.05).
DISCUSSION
In this study, infants with congenital CMV infection who were asymptomatic at birth with 
normal hearing by age 2 years were not at increased risk for intellectual impairment or low 
academic achievement compared to uninfected controls throughout adolescence. This 
confirms findings of smaller studies which found no significant difference in intelligence 
measures through early or late childhood.6, 7, 9–11, 13, 14, 32 Our study included infants 
identified through hospital-based newborn screening followed through adolescence, and 
provides new information on intellectual functioning, language and academic achievement 
of children with asymptomatic congenital CMV infection with and without SNHL compared 
to a group of uninfected children.
About 85–90% of children with congenital CMV infection are asymptomatic at birth. 
Findings from our study suggest that the majority of children that would be identified by 
newborn screening do not appear to be at increased risk of intellectual impairment and, 
therefore, may not need long-term monitoring for cognitive impairment/disabilities. 
Although this information could provide reassurance to parents, the psychosocial 
consequences, including increased parental anxiety, and other family-level impacts of CMV 
screening (i.e. time and costs incurred for regular monitoring) need to be systematically 
evaluated.33 More research is needed to understand the cost-benefit and minimize potential 
adverse psychosocial consequences of newborn screening for congenital CMV infection.
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Although we found no increased risk of intellectual impairment in children with 
asymptomatic congenital CMV infection, we did observe that children who had 
asymptomatic congenital CMV infection and developed SNHL by age 2 years had full-scale 
intelligence and receptive vocabulary scores that were lower than controls. However, their 
non-verbal intelligence and academic achievement scores in math and reading were not 
significantly different than controls, suggesting that the full-scale intelligence scores in case-
patients with SNHL were an underestimate of their intellectual potential. We are not aware 
of any study that has assessed the impact of SNHL on intelligence among children with 
asymptomatic congenital CMV infection. Significant differences in receptive vocabulary 
scores between case-patients and controls were likely attributable to SNHL rather than 
asymptomatic congenital CMV infection. Previously, we reported that the prevalence of 
SNHL among our asymptomatic case-patients nearly doubled from ages 3 months to 24 
months.19 Data from the CMV and Hearing Multicenter Screening Study revealed that 
nearly half of children with asymptomatic congenital CMV infection who are diagnosed 
with SNHL within 8 weeks of age are missed by newborn hearing screening.34 Screening of 
newborns for congenital CMV infection may allow early identification of SNHL in children 
with asymptomatic congenital CMV infection34 so that they can receive appropriate 
interventions to minimize delays in their communication, cognition, reading, and social-
emotional development.35 However, there is currently no consensus on audiologic 
monitoring for children with asymptomatic congenital CMV infection.36
In our cohort, we observed trends in intelligence, language and academic achievement that 
were intriguing. We found a modest increase in full-scale intelligence scores with increasing 
age in case-patients with either normal hearing or SNHL, and in controls. Trends and mean 
scores were similar when restricting the analysis to the WISC and WASI, which are 
administered to children between 6–18 years of age and provide more comparable measures 
of intelligence. Because intelligence measures are expected to remain unchanged over time, 
it is possible that the increasing scores with age reflect literacy or cultural gains among 
children, a phenomenon described as the Flynn effect.37 Previous studies of children with 
asymptomatic congenital CMV infection have also found slightly higher scores at older ages 
though the groups under comparison did not necessarily include the same group of children 
followed over time.5, 6 In contrast to the increasing trend in intelligence scores with 
increasing age, we found that receptive vocabulary scores increased up to age 12.5 years and 
then decreased, while scores for expressive vocabulary decreased with increasing age. These 
trends in receptive and expressive vocabulary scores were similar when excluding children 
who developed SNHL after age 2 years. Furthermore, scores in academic achievement in 
math, but not in reading, appeared to decrease with increasing age in all 3 groups. It is 
unclear if the amount of change in test scores that would be explained by age is of clinical 
importance. Nonetheless, it is possible that other domains of intellectual functioning (e.g. 
attention) or other factors (e.g., social, environmental) could have influenced children’s 
expressive vocabulary and academic achievement in math.
Our study had several strengths. Newborns with asymptomatic congenital CMV infection 
were identified through hospital-based screening, providing an opportunity to assess the full 
spectrum of outcomes among these children. The uninfected newborns followed as controls 
had no significant differences in sociodemographic characteristics. Thus, the control group 
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appeared to have been valid for comparisons. The comprehensive neurodevelopmental 
follow-up with multiple assessments through adolescence was important for understanding 
variability in scores over time. Finally, the robust analytical approach allowed for 
examination of trends in scores while controlling for variability within and between groups 
and imbalances in the number of assessments.
Nonetheless, our study had some limitations. Not all infants with congenital CMV infection 
identified through newborn screening were enrolled in the study and the number of 
uninfected children enrolled as controls was relatively small. A majority of children were 
born to mothers with at least some college education and medium/high socioeconomic 
status. Thus, the findings may not be generalized to populations with lower education level/
socioeconomic status.38 Our sample size was not large enough to include other potential risk 
factors in the analysis. Our control group had fewer evaluations than our case-patients. 
Nevertheless, the median age at the last assessment among the 3 groups was similar. We did 
not assess whether there were differences in specific cognitive domains, such as attention, 
perception, memory, and executive functioning, though we found no significant differences 
between case-patients and controls in exploratory analysis (not shown). Finally, data on 
interventions provided to children identified with asymptomatic infection were not 
systematically collected or assessed. Interventions provided for case-patients with SNHL 
may have helped minimize the impact of hearing loss on their intellectual functioning.
CONCLUSIONS
Our study suggests that infants with asymptomatic congenital CMV infection identified 
through newborn screening with normal hearing by age 2 years do not appear to have 
differences in intelligence quotient, vocabulary or academic achievement scores during 
childhood or adolescence compared with uninfected children. The implication that children 
with asymptomatic congenital CMV infection at birth may not need long-term monitoring 
for cognitive impairment/disabilities based on current evidence is of clinical importance. 
Further studies are needed to better understand the impact of asymptomatic congenital CMV 
infection on behavior and specific cognitive domains such as attention, perception, and 
memory.
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What’s Known on This Subject
The extent to which children with congenital cytomegalovirus infection who are 
asymptomatic at birth are at risk for intellectual impairment or low academic 
achievement throughout childhood is not well established.
What This Study Adds
Infants with asymptomatic congenital CMV infection identified through newborn 
screening who have normal hearing by age 2 years do not appear to have differences in 
intelligence quotient, vocabulary or academic achievement scores during childhood or 
adolescence compared with uninfected children.
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Table 1
Demographic characteristics of case-patients with and without sensorineural hearing loss by age 2 years and 
controls
Demographic characteristics Case-patients with normal hearing (n=78)
n (%)
Case-patients with SNHL
(n=11)
n (%)
Controls (n=40)
n (%) P-value
Gender
 Male 43 (55) 8 (73) 29 (73) 0.14
 Female 35 (45) 3 (27) 11 (28)
Mother’ age
 <20 years 1 (1) 0 (0) 0 (0)
 20–29 years 48 (62) 7 (64) 22 (55) 0.88
 30–39 years 28 (36) 4 (36) 18 (45)
 40–49 years 1 (1) 0 (0) 0 (0)
Mother’ race/ethnicity
 Non-Hispanic White 64 (82) 11 (100) 35 (88)
 Non-Hispanic Black 8 (10) 0 (0) 4 (10) 0.68
 Hispanic 6 (8) 0 (0) 1 (3)
Mother’ marital status
 Single 4 (5) 0 (0) 0 (0)
 Married 70 (90) 10 (91) 37 (93) 0.65
 Divorced 3 (4) 1 (9) 2 (5)
 Separated 1 (1) 0 (0) 1 (3)
Mother’ education 0.37
 Up to high school graduate 21 (27) 1 (9) 6 (15)
 Some college 24 (31) 6 (55) 13 (33)
 Graduated college 25 (32) 2 (18) 17 (43)
 Post-graduate degree 8 (10) 2 (18) 4 (10)
Health insurance
 None 3 (4) 0 (0) 1 (2)
 Private/HMO 60 (77) 7 (64) 19 (48) <0.01
 Medicaid 0 (0) 1 (9) 0 (0)
 Other/Unknown 15 (19) 3 (27) 20 (50)
Socioeconomic status
 Low 3 (4) 1 (9) 1 (2)
 Medium 28 (36) 4 (36) 9 (23) 0.35
 High 47 (60) 6 (55) 30 (75)
SNHL = sensorineural hearing loss
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Table 2
Neurodevelopmental assessments among case-patients with normal hearing or with sensorineural hearing loss 
by age 2 years and controls
Neurodevelopmental assessment
Case-patients
with normal
hearing (n=78)
Case-patients
with SNHL
(n=11)
Controls
(n=40)
Full scale intelligence
Number of children tested (%) 75 (96) 11 (100) 39 (98)
Median number of tests (IQR) 7 (5–8) 7 (6–8) 4 (2–5)
Median age at last assessment, years (IQR) 17.1 (14.5–17.5) 17.7 (17.4–18.3) 17.1 (14.6–17.6)
Verbal intelligence
Number of children tested (%) 72 (92) 10 (91) 35 (88)
Median number of tests (IQR) 4 (3–4) 4 (4–4) 3 (2–4)
Median age at last assessment, years (IQR) 17.2 (15.8–17.6) 17.8 (17.5–17.9) 17.4 (16.6–17.7)
Non-verbal intelligence
Number of children tested (%) 72 (92) 11 (100) 35 (88)
Median number of tests (IQR) 4 (3–4) 4 (3–4) 3 (2–4)
Median age at last assessment, years (IQR) 17.2 (15.8–17.6) 17.7 (17.4–17.9) 17.4 (16.6–17.7)
Receptive vocabulary
Number of children tested (%) 72 (92) 11 (100) 35 (88)
Median number of tests (IQR) 3 (2–4) 4 (3–5) 2 (2–3)
Median age at last assessment, years (IQR) 17.1 (14.6–17.6) 17.7 (17.4–17.9) 17.2 (15.6–17.6)
Expressive vocabulary
Number of children tested (%) 70 (90) 11 (100) 33 (83)
Median number of tests (IQR) 2.5 (2–3) 3 (2–3) 1 (1–2)
Median age at last assessment, years (IQR) 13.3 (10.1–13.7) 13.2 (11.3–13.6) 13.4 (12.3–14.1)
Academic achievement - Math
Number of children tested (%) 70 (90) 11 (100) 35 (88)
Median number of tests (IQR) 3 (2–4) 3 (3–4) 2 (2–3)
Median age at last assessment, years (IQR) 17.2 (16.4–17.6) 17.7 (17.4–17.9) 17.4 (16.9–17.7)
Academic achievement - Reading
Number of children tested (%) 70 (90) 11 (100) 35 (88)
Median number of tests (IQR) 3 (2–4) 3 (3–4) 2 (2–3)
Median age at last assessment, years (IQR) 17.2 (16.4–17.6) 17.7 (17.4–17.9) 17.2 (16.4–17.6)
SNHL = sensorineural hearing loss
IQR = interquartile range
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